Insider Trading in U.S. Stocks | Centessa Discloses 5 Insider Transactions on March 13

robot
Abstract generation in progress

On March 13, 2026, Centessa (CNTA) disclosed five insider trading transactions. Executive Anderson Karen M. bought 109.4k shares on March 13, 2026.

【Recent Insider Transactions】

Disclosure Date Position Name Transaction Date Buy/Sell Quantity Price per Share/USD Total Amount/USD
March 13, 2026 Executive Anderson Karen M. March 13, 2026 Sell 12.1k 27.13 327.4k
March 13, 2026 Executive Weinhoff Gregory M March 13, 2026 Sell 61.3k 26.17 1.6M
March 13, 2026 Executive Anderson Karen M. March 13, 2026 Buy 109.4k 4.01 438.7k
March 13, 2026 Executive Anderson Karen M. March 13, 2026 Sell 108k 26.15 2.82M
March 13, 2026 Executive Weinhoff Gregory M March 13, 2026 Sell 11.9k 27.16 324.3k
February 3, 2026 Executive HUSSAIN IQBAL J February 1, 2026 Sell 7,780 24.57 191.2k
February 3, 2026 Executive Weinhoff Gregory M February 1, 2026 Sell 14.2k 24.57 347.9k
February 3, 2026 Executive HUSSAIN IQBAL J January 30, 2026 Sell 1,010 25.01 25.3k
February 3, 2026 Executive HUSSAIN IQBAL J February 2, 2026 Sell 39k 25.15 979.7k
February 3, 2026 Executive Anderson Karen M. February 1, 2026 Sell 10.6k 24.57 260.6k

【Company Information】

Centessa Pharmaceuticals plc was incorporated in the UK on October 26, 2020. The company is a clinical-stage pharmaceutical company dedicated to discovering, developing, and ultimately delivering transformative medicines for patients.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin